Aarti Pharmalabs Limited (BOM:543748)

Market Cap	58.36B -19.0%
Revenue (ttm)	18.19B -14.0%
Net Income	1.75B -35.9%
EPS	19.25 -35.9%
Shares Out	n/a
PE Ratio	33.40
Forward PE	39.25
Dividend	4.00 (0.64%)
Ex-Dividend Date	Feb 16, 2026

Volume	10,221
Open	615.10
Previous Close	622.55
Day's Range	613.10 - 651.15
52-Week Range	583.85 - 971.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 25, 2026

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con...

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 2,162
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543748

Financial Performance

In fiscal year 2026, Aarti Pharmalabs's revenue was 18.19 billion, a decrease of -13.98% compared to the previous year's 21.15 billion. Earnings were 1.75 billion, a decrease of -35.86%.